3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Neoplasm Metastasis
4
Carcinoma, Transitional Cell
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Glioblastoma
2
Clear-cell metastatic renal cell carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Basal Cell
2
Vulvar Neoplasms
1
Ureteral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Rectal Neoplasms
1
Interventions
Paclitaxel
16
pembrolizumab
15
Carboplatin
13
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Biopsy
7
Bevacizumab
7
Fulvestrant
6
olaparib
5
Taxes
5
Megestrol Acetate
5
Doxorubicin
5
Cisplatin
5
trastuzumab deruxtecan
4
dostarlimab
4
Nivolumab
4
Gemcitabine
4
palbociclib
3
durvalumab
3
Progestins
3
Oxaliplatin
3
Medroxyprogesterone Acetate
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Docetaxel
3
Disulfides
3
ribociclib
2
pertuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.